Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast.
Amylou C DueckBrittany L SiontisSafia K AhmedTanya L HoskinTina J HiekenJames W JakubChristian L BaumCourtney DaySarah E SchrupLauren SmithJodi M CarterTiffany M Sae-KhoKatrina N GlazebrookAparna VijayasekaranScott H OkunoIvy A PetersenPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Trimodality therapy for RAASB was more toxic but is promising with a high rate of pCR, durable local control, and improved RFS.